首頁 > 市場調查報告書 > 醫療設備

整形外科

市場調查報告書

商品編碼

1439957

骨科植入物 - 全球市場回顧、競爭格局、市場預測（2030）

Orthopedic Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 按訂單生產 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

預計2024-2030年期間，全球骨科植入物市場規模將以5.46%的複合年增長率成長。該市場的推動因素包括關節炎和骨質疏鬆症等骨科疾病的日益流行、人口老化負擔的增加、道路交通事故和其他傷害數量的增加，以及人們對醫療器材的安全性、可用性和易用性的日益擔憂。骨科植入物。在預測期內（2024-2030 年），日益關注改進等因素預計將蓬勃發展，並預計市場收入將出現顯著增長。

骨科植入物市場動態

根據世界衛生組織（WHO）（2022）的數據，肌肉骨骼疾病是導致殘疾的主要原因，全球約有 17.1 億人患有骨質疏鬆症、骨關節炎和類風濕性關節炎等肌肉骨骼疾病。

骨關節炎，也稱為退化性關節炎或磨料性關節炎，會影響關節，導致光滑的軟骨隨著時間的推移從骨骼表面磨損。因此，患者會面臨關節發炎、腫脹和疼痛，進而影響人的整體運動。在嚴重的情況下，患者必須接受骨科植入手術。

根據世界衛生組織 (WHO) 的數據，2019 年全球約有 5.28 億人患有骨關節炎。據同一消息來源稱，2019 年全球有 1800 萬人患有類風濕性關節炎。

此外，根據上述數據，2019年，骨關節炎在全球造成了1,900萬YLD（失能壽命）（years lived with disability），類風濕性關節炎在全球造成了240萬YLD。

交通事故的增加也是推動骨科植入物市場成長的主要因素。突發交通事故造成的輕微或致命傷害有時會導致殘疾，增加對骨科植入物的需求，並對骨科植入物市場的成長產生正面影響。根據世界衛生組織（2022）的數據，每年約有 130 萬人因道路事故死亡，約 20 至 5000 萬人遭受非致命傷害或某種形式的殘疾。

然而，高昂的手術成本、修復手術的需要以及骨科植入物的嚴格監管批准可能會限制骨科植入物市場的成長。

COVID-19大流行對骨科植入物市場產生了輕微影響。疫情的爆發導致門診取消、非急診醫院和程序暫停。結果，骨科測試和手術減少了。根據經濟合作暨發展組織（OECD）（2023）的統計，2020年愛爾蘭和義大利的髖關節置換術數量比2019年減少了近20%，挪威和歐洲的髖關節置換術數量減少了10%以上。捷克共和國：出現下降。此外，在 COVID-19 大流行期間，骨科植入物的製造、進出口和其他相關活動受到阻礙。然而，隨著COVID-19疫苗的研發，封鎖規定的放鬆和經濟狀況的正常化，門診等正常醫療服務的恢復，骨科植入物市場的產品需求也恢復正常。經濟復甦已經開始。

骨科植入物市場細分分析

在骨科植入物產品類型領域，預計膝關節植入物類別在預測期內（2024-2030 年）整個市場的收入將顯著增長。

膝關節植入物往往可以減輕骨骼疾病和損傷引起的疼痛，比膝關節注射和抗發炎藥物等非手術治療更能減輕患者的痛苦。

全膝關節置換術後，患者的疼痛、活動能力和生活品質得到改善。您可以毫無問題地恢復日常生活。

根據2022年經濟合作暨發展組織（OECD）統計，2019年，每10萬人中約有260例人為死亡，瑞士、德國227例、澳洲211例、韓國153例、英國142例，進行膝關節置換手術。根據相同數據，2019年平均膝關節置換手術為每10萬人137例。植入材料、設計和手術技術的新技術進步有助於將膝關節植入物的使用壽命延長約 10 至 15 年。

本報告提供了全球骨科植入物市場的研究和分析，包括市場規模和預測、驅動因素和挑戰、公司和產品概況。

Zimmer Biomet
Stryker
Johnson & Johnson Services, Inc.
Biotek (Chetan Meditech Pvt. Ltd.)
CONMED Corporation
Medtronic
Enovis
Smith+Nephew
B. Braun SE
Exactech, Inc.
Corin Group
Conformis
Medacta International
Globus Medical
Arthrex, Inc.
Meril Life Sciences Pvt. Ltd.
Auxein Medical
United Orthopedic Corporation
Limacorporate S.p.A.
NuVasiveR, Inc.

第9章 KOL觀點

第10章項目方法

第 11 章關於 DelveInsight

第十二章免責聲明與聯絡我們

簡介目錄圖表

Product Code: DIMDCL0638

Orthopedic Implants Market By Product Type (Hip Implants, Knee Implants, Spinal Implants, Foot And Ankle Implants, And Others), By End-User (Hospitals, Orthopedic Clinics, And Others ), by geography is estimated to register growth at a remarkable CAGR forecast during 2024-2030 owing to increasing prevalence of orthopedic diseases and rising demand for personalized orthopedic implants

The global orthopedic implants market is estimated to grow at a CAGR of 5.46% during the forecast period from 2024 to 2030. The orthopedic implants market is slated to witness prosperity owing to factors such as the increasing prevalence of orthopedic diseases such as arthritis, osteoporosis, and others, a growing burden of the geriatric population, the rising number of road accidents associated and other injuries, and the growing focus on improving the safety, affordability, and usability of orthopedic implants for people are further expected to result in the appreciable revenue growth in the orthopedic implants market during the forecast period (2024-2030).

Orthopedic Implants Market Dynamics:

According to World Health Organization (WHO) 2022, musculoskeletal conditions are the leading contributor to disability, and worldwide around 1.71 billion people are suffering from musculoskeletal diseases such as osteoporosis, osteoarthritis, rheumatoid arthritis, and others.

Osteoarthritis also known as degenerative or wear-and-tear arthritis affects the joints and with time leads to the wearing off of smooth cartilage from the surface of bones. This causes patients to face inflammation, swelling, and pain in joints affecting the overall movement of a person. In severe cases, patients have to undergo orthopedic implant surgery.

According to World Health Organization 2022, worldwide around 528 million people suffered from osteoarthritis in 2019. As per the same source, worldwide 18 million people had rheumatoid arthritis in 2019.

Also, according to the above-mentioned source osteoarthritis contributed to 19 million years lived with disability (YLDs), while rheumatoid arthritis contributed to 2.4 million YLDs globally in 2019.

The rise in road traffic accidents is another major factor driving the growth of the orthopedic implants market. Light and fatal injuries owing to sudden road accidents lead to disability sometimes and increase the need for orthopedic implants, positively impacting the growth of the orthopedic implants market. According to WHO 2022, approximately 1.3 million people die each year because of road traffic accidents and around 20-50 million individuals suffer from non-fatal injuries or some sort of disability.

However, the high cost of the procedure coupled with the need to undergo revision surgery and stringent regulatory approval for orthopedic implants may act as a restraint in the market growth for orthopedic implants.

The COVID-19 pandemic has slightly impacted the market for orthopedic implants. The outbreak of the pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitals and procedures. This resulted in a reduced number of orthopedic examinations and procedures. As per Organization for Economic Cooperation and Development (OECD) statistics (2023), a nearly 20% drop in hip replacements was observed in 2020 in Ireland and Italy, and a more than 10% drop in Norway and the Czech Republic compared to 2019. Also, the manufacturing, import, export, and other related activities of orthopedic implants were hampered during the period of COVID- 19 pandemic. However, the vaccine development of COVID-19 has initiated the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape which has initiated the process of resumption of regular healthcare services such as outpatients visits, thereby bringing the demand for products on track in the orthopedic implants market.

Orthopedic Implants Market Segment Analysis:

Orthopedic Implants Market by Product Type (Hip Implants, Knee Implants, Spinal Implants, Foot and Ankle Implants, and Others), End-User (Hospitals, Orthopedic Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Based on the product type segment of orthopedic implants, the knee implants category is projected to register a significant growth in revenue in the overall orthopedic implants market during the forecast period (2024-2030).

Knee implants tend to reduce the pain due to any bone disease or injury and provide adequate relief to the patient over non-operative treatments such as knee injections, anti-inflammatory medications, and others.

Post-knee implantation patients witness improvements in pain, mobility, and quality of life. They can return to doing day-to-day tasks without much hindrance.

As per Organization for Economic Cooperation and Development (OECD) statistics for 2022, about 260 knee replacement surgeries in Switzerland, 227 in Germany, 211 in Australia, 153 in Korea, and 142 in the United Kingdom, per 100,000 population were performed in 2019. As per the same source, the average for knee replacement surgery was 137 per 100,000 population in 2019. The newer technological advancements in implant material, design, and surgical technique have facilitated in increasing the longevity of knee implants by about 10-15 years.

Thereby, considering the growing demand for this product type, numerous new products are being developed and launched in the market. For example, in November 2022, Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, obtained 510(k) clearance from the US Food and Drug Administration to market the TriVerse(TM) primary knee system.

Therefore, considering the advantages associated with knee implants and their growing popularity, this product category is expected to generate considerable revenue thereby pushing the overall growth of the global orthopedic implants market during the forecast period.

North America is expected to dominate the overall Orthopedic Implants Market:

Among all the regions, North America is expected to lead in revenue generation in the global orthopedic implants market. This can be due to factors including the prevalence of chronic bone diseases, the increasing old age population, and the presence of key companies involved in the production of orthopedic implants, high-tech medical facilities, and others.

One of the prominent factors supporting the growth of the North America orthopedic implants market is the prevalence of chronic bone diseases leading to disability, majorly in the United States. The rising prevalence of arthritis in the US is the major factor responsible for the growth of the orthopedic implants market in the region. As per the Centers for Disease Control and Prevention (CDC) 2022, it has been estimated that there will be around 78.4 million people suffering from doctor-diagnosed arthritis by 2040, and out of that two-thirds will be the women population.

As per the same source, an estimated 34.6 million adults will face arthritis-attributable activity limitations in the US by 2040. As per Arthritis Foundation 2022, around 1.5 million people have rheumatoid arthritis in the United States.

The increasing age makes one susceptible to several health issues including bone diseases, and others, and thus is another driver for the growth of the orthopedic implants market. According to CDC 2022, around 54.1 million US adults were aged 65 or older in 2019. As per the same source, it has been estimated that by 2060, this number will reach up to 94.7 million in the US. Along with the presence of a large patient pool in the country, the increasing focus of manufacturers on launching new products in the market is expected to bolster the growth of the orthopedic implants market in the United States during the forecast period.

For example, in February 2020, In2Bones Global, Inc. received the US Food and Drug Administration clearance to market the Quantum(TM) Total Ankle Replacement System. Therefore, the above-mentioned factors are expected to bolster the growth of the orthopedic implants market in the United States during the forecast period.

Orthopedic Implants Market Key Players:

Some of the key market players operating in the orthopedic implants market include Smith+Nephew, Stryker, Zimmer Biomet, Johnson & Johnson Services, Inc.Biotek (Chetan Meditech Pvt. Ltd.), CONMED Corporation, Medtronic, Enovis, B. Braun SE, Corin Group, Exactech, Inc., Meril Life Sciences Pvt. Ltd., Arthrex, Inc., Conformis, Medacta International, Globus Medical, Auxein Medical, United Orthopedic Corporation, Limacorporate S.p.A., NuVasive®, Inc., and others.

Recent Developmental Activities in the Orthopedic Implants Market:

In September 2022, Zimmer Biomet Holdings, Inc., a global medical technology leader, received the US Food and Drug Administration (FDA) 510(k) clearance of the Identity(TM) Shoulder System for anatomic, reverse, and revision shoulder replacement.

In September 2022, Tyber Medical, LLC, a leading orthopedic device manufacturer providing private-label ORTHOPEDIC Implants for the trauma, extremity, and spine markets, received its second and largest US FDA 510(k) clearance for its expanded line of anatomical plating systems.

In July 2020, Orthofix Medical Inc., a global medical device company focused on musculoskeletal healing products received the US FDA 510(k) clearance and European CE Mark approval for the JuniOrtho® Plating System which is designed to address the demands of advanced deformity and trauma reconstruction of the lower extremities.

Key Takeaways from the Orthopedic Implants Market Report Study

Market size analysis for current orthopedic implants market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the orthopedic implant market.

Top key product developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years

Key companies dominating the global orthopedic implants market.

Various opportunities available for the other competitor in the orthopedic implants market space.

What are the top-performing segments in 2023? How these segments will perform in 2027?

Which are the top-performing regions and countries in the current orthopedic implants market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for orthopedic implants market growth in the coming future?

Target Audience who can be benefited from this Orthopedic Implants Market Report Study

Orthopedic implants products providers

Research organizations and consulting companies

Orthopedic Implants -related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in orthopedic implants

Various distribution channels who want to know more about the orthopedic implants market and the latest product innovations in the orthopedic Implants market.

Frequently Asked Questions for the Orthopedic Implants Market:

1. What are orthopedic implants?

Orthopedic implants are intended for the replacement of a joint, bone, or cartilage owing to some damage or deformity that happened due to any disease or injury and include knee, shoulder, hip, foot, and ankle implants among others.

2. What is the market for global orthopedic Implants?

The global orthopedic implants market is estimated to grow at a CAGR of 5.46% during the forecast period from 2024 to 2030.

3. What are the drivers for the global orthopedic implants market?

The orthopedic implants market is slated to witness prosperity owing to factors such as the increasing prevalence of orthopedic diseases, rising cases of road accidents and other traumatic injuries, the growing burden of the geriatric population, increasing demand for personalized orthopedic implants, rising technological advancements, and the growing focus on improving the safety and usability of orthopedic implants for people are further expected to result in the appreciable revenue growth in the orthopedic implants market during the forecast period (2024-2030).

4. Who are the key players operating in the global orthopedic implants market?

5. Which region has the highest share in the orthopedic implants market?

North America is expected to dominate the overall orthopedic implants market during the forecast period, 2024 to 2030. This can be ascribed to the increasing patient population suffering from orthopedic implants for regular household cleaning and sanitation activities and for maintaining personal hygiene, increasing disposable personal income, and a highly potent market in terms of product development and launches, and the local presence of key market players among other factors in the region.

1.Orthopedic Implants Market Report Introduction

2. Orthopedic Implants Market Executive Summary

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment

3. Regulatory Analysis

3.1. The United States
3.2. Europe
3.3. Japan
3.4. China

4. Orthopedic Implants Market Key Factors Analysis

4.1. Orthopedic Implants Market Drivers
- 4.1.1. Increasing prevalence of orthopedic diseases
- 4.1.2. Rising number of road accidents and other traumatic injuries
- 4.1.3. The growing burden of the geriatric population
4.2. Orthopedic Implants Market Restraints and Challenges
- 4.2.1. High cost of procedures coupled with the need to undergo revision surgery
- 4.2.2. Stringent regulatory policies for orthopedic implants
4.3. Orthopedic Implants Market Opportunities
- 4.3.1. Increasing demand for personalized orthopedic implants
- 4.3.2. The growing concept of smart orthopedic implants

5. Orthopedic Implants Market Porter's Five Forces Analysis

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Orthopedic Implants Market

7. Orthopedic Implants Market Layout

7.1. By Product Type
- 7.1.1. Hip Implants
- 7.1.2. Knee Implants
- 7.1.3. Spinal Implants
- 7.1.4. Foot and Ankle Implants
- 7.1.5. Others
7.2. By End-User
- 7.2.1. Hospitals
- 7.2.2. Orthopedic Clinics
- 7.2.3. Others
7.3. By Geography
- 7.3.1. North America
  - 7.3.1.1. United States Orthopedic Implants Market in USD million (2021-2030)
  - 7.3.1.2. Canada Orthopedic Implants Market in USD million (2021-2030)
  - 7.3.1.3. Mexico Orthopedic Implants Market in USD million (2021-2030)
- 7.3.2. Europe
  - 7.3.2.1. France Orthopedic Implants Market in USD million (2021-2030)
  - 7.3.2.2. Germany Orthopedic Implants Market in USD million (2021-2030)
  - 7.3.2.3. United Kingdom Orthopedic Implants Market in USD million (2021-2030)
  - 7.3.2.4. Italy Orthopedic Implants Market in USD million (2021-2030)
  - 7.3.2.5. Spain Orthopedic Implants Market in USD million (2021-2030)
  - 7.3.2.6. Rest of Europe Orthopedic Implants Market in USD million (2021-2030)
- 7.3.3. Asia-Pacific
  - 7.3.3.1. China Orthopedic Implants Market in USD million (2021-2030)
  - 7.3.3.2. Japan Orthopedic Implants Market in USD million (2021-2030)
  - 7.3.3.3. India Orthopedic Implants Market in USD million (2021-2030)
  - 7.3.3.4. Australia Orthopedic Implants Market in USD million (2021-2030)
  - 7.3.3.5. South Korea Orthopedic Implants Market in USD million (2021-2030)
  - 7.3.3.6. Rest of the Asia Pacific Orthopedic Implants Market in USD million (2021-2030)
- 7.3.4. Rest of the World (RoW)
  - 7.3.4.1. Middle East Orthopedic Implants Market in USD million (2021-2030)
  - 7.3.4.2. Africa Orthopedic Implants Market in USD million (2021-2030)
  - 7.3.4.3. South America Orthopedic Implants Market in USD million (2021-2030)

8. Orthopedic Implants Market Company and Product Profiles

8.1. Zimmer Biomet
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. Stryker
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. Johnson & Johnson Services, Inc.
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. Biotek (Chetan Meditech Pvt. Ltd.)
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. CONMED Corporation
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. Medtronic
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. Enovis
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. Smith+Nephew
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. B. Braun SE
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy
8.10. Exactech, Inc.
- 8.10.1. Company Overview
- 8.10.2. Company Snapshot
- 8.10.3. Financial Overview
- 8.10.4. Product Listing
- 8.10.5. Entropy
8.11. Corin Group
- 8.11.1. Company Overview
- 8.11.2. Company Snapshot
- 8.11.3. Financial Overview
- 8.11.4. Product Listing
- 8.11.5. Entropy
8.12. Conformis
- 8.12.1. Company Overview
- 8.12.2. Company Snapshot
- 8.12.3. Financial Overview
- 8.12.4. Product Listing
- 8.12.5. Entropy
8.13. Medacta International
- 8.13.1. Company Overview
- 8.13.2. Company Snapshot
- 8.13.3. Financial Overview
- 8.13.4. Product Listing
- 8.13.5. Entropy
8.14. Globus Medical
- 8.14.1. Company Overview
- 8.14.2. Company Snapshot
- 8.14.3. Financial Overview
- 8.14.4. Product Listing
- 8.14.5. Entropy
8.15. Arthrex, Inc.
- 8.15.1. Company Overview
- 8.15.2. Company Snapshot
- 8.15.3. Financial Overview
- 8.15.4. Product Listing
- 8.15.5. Entropy
8.16. Meril Life Sciences Pvt. Ltd.
- 8.16.1. Company Overview
- 8.16.2. Company Snapshot
- 8.16.3. Financial Overview
- 8.16.4. Product Listing
- 8.16.5. Entropy
8.17. Auxein Medical
- 8.17.1. Company Overview
- 8.17.2. Company Snapshot
- 8.17.3. Financial Overview
- 8.17.4. Product Listing
- 8.17.5. Entropy
8.18. United Orthopedic Corporation
- 8.18.1. Company Overview
- 8.18.2. Company Snapshot
- 8.18.3. Financial Overview
- 8.18.4. Product Listing
- 8.18.5. Entropy
8.19. Limacorporate S.p.A.
- 8.19.1. Company Overview
- 8.19.2. Company Snapshot
- 8.19.3. Financial Overview
- 8.19.4. Product Listing
- 8.19.5. Entropy
8.20. NuVasive®, Inc.
- 8.20.1. Company Overview
- 8.20.2. Company Snapshot
- 8.20.3. Financial Overview
- 8.20.4. Product Listing
- 8.20.5. Entropy